SLDE
Slide Insurance Holdings, Inc.
$27.34
+0.79% 2026-10-20
Financial Services
SLDESPY
1W
+7.2%
1M
+9.6%
3M
+33.4%
6M
+44.5%
YTD
+40.8%
1Y
+83.5%
Live chart
Loading live chart…
Grades vs sector
MomentumNot enough data yet–
Momentum
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
GrowthNot enough data yet–
Growth
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
ValueNot enough data yet–
Value
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
ProfitabilityNot enough data yet–
Profitability
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
Revisions
Not enough data yet
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 5 live models right now.
Quality Growth
not ranked (outside this model's universe or screens)
Momentum Top 15not ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
New Highs Growthnot ranked (outside this model's universe or screens)
Conviction 20not in the current book
News
More newsEarnings Preview: Slide Insurance Holdings, Inc. (SLDE) Q3 Earnings Expected to Decline
Zacks · 17h ago
Slide Insurance Holdings (SLDE) Stock Sees Modest Fair Value Lift After Analyst Target Changes
Simply Wall St. · Oct 14
Slide to Report 2026 Third Quarter Earnings Results on October 27, 2026
GlobeNewswire · Oct 01
Slide Insurance Holdings (SLDE) Could Be 6% Undervalued As South Carolina Expansion Draws Focus
Simply Wall St. · Sep 25
Slide Insurance Holdings (SLDE) Stock May Be Undervalued Despite South Carolina Expansion
Simply Wall St. · Sep 24
Key stats
Market cap$3.2B
P/E (trailing)6.6
P/E (forward)7.5
52-week range14.56 – 27.65
Revenue growth (YoY, latest qtr)+47.9%
Dividend yield1.03%
Analyst consensusBuy (5)
Mean price target$26.40 (-3%)
Valuation and fundamentals
Valuation & fundamentals
Bottom line
Leans undervalued
Model read-out from the numbers below, not advice. Score +2 (DCF counts double).
▲DCF (base case)above the price by 2097%
•Piotroski F-score5/9
•Analyst target-3% (5 analysts)
Discounted cash flow
Bear
$268
+881%
growth 18% · disc. 10.2% · term. 2.0%
Base
$601
+2097%
growth 30% · disc. 9.2% · term. 2.5%
Bull
$1,138
+4061%
growth 38% · disc. 8.2% · term. 3.0%
A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Today's price implies shrinking cash flows: about -30% a year for 10 years.
Implied
-30%/yr
FCF, last 3 yrs
n/a
FCF, last 5 yrs
n/a
Revenue, last 3 yrs
n/a
Revenue, last 5 yrs
n/a
Same inputs as the DCF above: trailing free cash flow 1.0B, 9.2% discount rate, 2.5% growth after year 10, net cash and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.00 (n/a) × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs sector
Forward EPS $3.64 vs trailing $4.12 (-12% expected growth). Forward P/E uses analysts' next-12-month estimate.
Quality & financial health
Gross margin
–
Operating margin
–
FCF margin
74.5%
Net margin
40.0%
Return on equity
46.5%
Return on invested capital
–
Net debt / EBITDA
–
Current ratio
–
Interest cover
–
Cash conversion (OCF/NI)
1.9×
Piotroski F-score 5/9 · last two fiscal years
✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✗ No share dilution✗ Gross margin improved✗ Asset turnover improved
Analysts
Mean target
$26
-3%
Analysts
5
Buy
Range
$22–$28
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $1.2B | $444.0M | $794.6M |
| 2024 | $846.8M | $201.1M | $543.8M |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR –.
Earnings
Next report: 2026-10-27 · after close · EPS est 0.84
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-07-28 | 0.86 | 1.06 | +23.9% |
| 2026-04-28 | 0.86 | 1.02 | +18.1% |
| 2026-02-24 | 0.88 | 1.23 | +40.1% |
| 2025-11-06 | 0.50 | 0.79 | +58.0% |
| 2025-08-12 | 0.44 | 0.56 | +27.8% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $386.8M | +47.9% |
| 2026-03-31 | $389.3M | – |
| 2025-12-31 | $347.0M | – |
| 2025-09-30 | $265.7M | – |
| 2025-06-30 | $261.6M | – |
Analyst actions
Citizens
PT $28
2026-10-12 · main
Market Outperform → Market OutperformPT $28
Keefe, Bruyette & Woods
PT $26
2026-08-03 · main
Outperform → OutperformPT $26
Citizens
PT $27
2026-07-30 · main
Market Outperform → Market OutperformPT $27
Barclays
PT $28
2026-07-29 · main
Overweight → OverweightPT $28
Keefe, Bruyette & Woods
PT $24
2026-07-08 · main
Outperform → OutperformPT $24
Barclays
PT $27
2026-07-07 · main
Overweight → OverweightPT $27
Recent dividends
2026-08-14: $0.070
Insider trades
Rohde Stephen L
$198.0K
Director · 2026-09-14
SELL$198.0K
Larson Matthew Paul
$295.7K
Chief Risk Officer · 2026-09-14
SELL$295.7K
Omiridis Anastasios
$8.7K
Chief Financial Officer · 2026-09-14
SELL$8.7K
Gries Robert Jr
$1.5M
Director · 2026-09-09
SELL$1.5M
Gries Robert Jr
$2.6M
Director · 2026-09-08
SELL$2.6M
Powell Charles William
$52.0K
Chief Revenue Officer · 2026-09-03
SELL$52.0K
Larson Matthew Paul
$280.0K
Chief Risk Officer · 2026-09-03
SELL$280.0K
Rohde Stephen L
$109.5K
Director · 2026-08-14
SELL$109.5K
Rohde Stephen L
$105.0K
Director · 2026-08-06
SELL$105.0K
Gries Robert Jr
$576.7K
Director · 2026-08-04
SELL$576.7K
Gries Robert Jr
$573.5K
Director · 2026-08-03
SELL$573.5K
Rohde Stephen L
$100.0K
Director · 2026-07-31
SELL$100.0K
Stats refreshed 2026-10-20 18:03:38 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Coteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.